Johnson and Johnson (JNJ) has revealed that there is no evidence to support the use of Darunavir for the treatment of COVID-19. There have been anecdotal, unsubstantiated reports claiming that Darunavir has antiviral effects against the novel coronavirus.
from RTT - Biotech https://ift.tt/2Wl0SUL
via IFTTT
No comments:
Post a Comment